DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) — MannKind (NASDAQ:) Company (Nasdaq: MNKD), introduced in the present day that it’s going to report its second quarter 2024 monetary outcomes earlier than the market opens on Wednesday, August 7, 2024. A press launch detailing the quarterly outcomes might be issued the identical day roughly one hour previous to the webcast.
MannKind will host a webcast starting at 9:00 a.m. Jap Time for buyers, media, and most of the people. Taking part within the convention name from MannKind might be Chief Govt Officer Michael Castagna, PharmD, and Chief Monetary Officer Chris Prentiss. The webcast might be accessible by way of a hyperlink on MannKind’s web site at https://buyers.mannkindcorp.com/events-and-presentations. A replay can even be accessible in the identical location inside 24 hours following the decision and be accessible for roughly 90 days.
About MannKind
MannKind Company (Nasdaq: MNKD) focuses on the event and commercialization of progressive inhaled therapeutic merchandise and units to handle critical unmet medical wants for these dwelling with endocrine and orphan lung ailments.
We’re dedicated to utilizing our formulation capabilities and gadget engineering prowess to minimize the burden of ailments reminiscent of diabetes, nontuberculous mycobacterial (N™) lung illness, pulmonary fibrosis, and pulmonary hypertension. Our signature applied sciences “ dry-powder formulations and inhalation units “ provide speedy and handy supply of medicines to the deep lung the place they’ll exert an impact domestically or enter the systemic circulation, relying on the goal indication.
With a passionate workforce of Mannitarians collaborating nationwide, we’re on a mission to present folks management of their well being and the liberty to dwell life.
Please go to mannkindcorp.com to be taught extra, and observe us on LinkedIn, Fb (NASDAQ:), X or Instagram.